These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34265768)

  • 1. Inflammatory Biomarkers as Promising Predictors of Prognosis in Cervical Cancer Patients.
    Domenici L; Tonacci A; Aretini P; Garibaldi S; Perutelli A; Bottone P; Muzii L; Benedetti Panici P
    Oncology; 2021; 99(9):571-579. PubMed ID: 34265768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
    Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
    Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
    Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
    J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory parameters as predictors of prognosis in uterine cervical neoplasia.
    Lima PSV; Mantoani PTS; Murta EFC; Nomelini RS
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():391-396. PubMed ID: 33279808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer.
    Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
    Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review.
    Kozasa K; Mabuchi S; Komura N; Yokoi E; Hiromasa K; Sasano T; Kawano M; Matsumoto Y; Kobayashi E; Kimura T
    Oncotarget; 2017 Aug; 8(33):55394-55404. PubMed ID: 28903428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
    Ma JY; Ke LC; Liu Q
    Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
    Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
    Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer.
    Sun Z; Ju Y; Han F; Sun X; Wang F
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28605139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
    Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
    Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of pretreatment inflammatory biomarkers in primary small cell carcinoma of the esophagus.
    Wang N; Li X; Luo H; Sun Y; Zheng X; Fan C; Wang H; Ye K; Ge H
    Thorac Cancer; 2019 Oct; 10(10):1913-1918. PubMed ID: 31389159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer systemic inflammation score: a novel predictor of prognosis.
    Zheng RR; Huang M; Jin C; Wang HC; Yu JT; Zeng LC; Zheng FY; Lin F
    Oncotarget; 2016 Mar; 7(12):15230-42. PubMed ID: 26885692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic markers of distant metastases and poor prognosis in gynecological cancers.
    Abu-Shawer O; Abu-Shawer M; Hirmas N; Alhouri A; Massad A; Alsibai B; Sultan H; Hammo H; Souleiman M; Shebli Y; Al-Hussaini M
    BMC Cancer; 2019 Feb; 19(1):141. PubMed ID: 30755184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery.
    Yu J; Ding Z; Yang Y; Liu S
    Medicine (Baltimore); 2018 Jun; 97(25):e11002. PubMed ID: 29923983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Peritumoral IL-17-Positive Cells and IL-17 Axis in Patients with Intrahepatic Cholangiocarcinoma.
    Asukai K; Kawamoto K; Eguchi H; Konno M; Nishida N; Koseki J; Noguchi K; Hasegawa S; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Noda T; Wada H; Gotoh K; Marubashi S; Nagano H; Doki Y; Mori M; Ishii H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1524-31. PubMed ID: 26228109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Use of Pretreatment Hematologic Parameters in Patients Receiving Definitive Chemoradiotherapy for Cervical Cancer.
    Onal C; Guler OC; Yildirim BA
    Int J Gynecol Cancer; 2016 Jul; 26(6):1169-75. PubMed ID: 27206286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
    Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
    Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.